SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acro Biomedical Co., Ltd. – ‘10-Q’ for 6/30/22 – ‘R6’

On:  Friday, 8/12/22, at 4:17pm ET   ·   For:  6/30/22   ·   Accession #:  1640334-22-1752   ·   File #:  0-55643

Previous ‘10-Q’:  ‘10-Q’ on 5/16/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/21/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 8/14/23 for 6/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/22  Acro Biomedical Co., Ltd.         10-Q        6/30/22   37:1.7M                                   Pubco Reporting … Inc/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    456K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     13K 
 9: R1          Cover                                               HTML     61K 
10: R2          Balance Sheets                                      HTML     99K 
11: R3          Balance Sheets (Parenthetical)                      HTML     30K 
12: R4          Statements of Operations (Unaudited)                HTML     74K 
13: R5          Statements of Changes in Stockholders' Equity       HTML     54K 
                (Unaudited)                                                      
14: R6          Statements of Cash Flows (Unaudited)                HTML     66K 
15: R7          Organization and Description of Business            HTML     18K 
16: R8          Summary of Significant Accounting Policies          HTML     25K 
17: R9          Going Concern                                       HTML     16K 
18: R10         Related Party Transactions                          HTML     16K 
19: R11         Leases                                              HTML     26K 
20: R12         Stockholders' Equity                                HTML     19K 
21: R13         Concentration                                       HTML     15K 
22: R14         Subsequent Events                                   HTML     15K 
23: R15         Summary of Significant Accounting Policies          HTML     39K 
                (Policies)                                                       
24: R16         Leases (Tables)                                     HTML     26K 
25: R17         Summary of Significant Accounting Policies          HTML     14K 
                (Details Narrative)                                              
26: R18         Related Party Transactions (Details Narrative)      HTML     27K 
27: R19         Leases (Details)                                    HTML     14K 
28: R20         Leases (Details 1)                                  HTML     18K 
29: R21         Leases (Details 2)                                  HTML     21K 
30: R22         Leases (Details Narrative)                          HTML     20K 
31: R23         Stockholders' Equity (Details Narrative)            HTML     33K 
32: R24         Concentration (Details Narrative)                   HTML     24K 
35: XML         IDEA XML File -- Filing Summary                      XML     58K 
33: XML         XBRL Instance -- acro_10q_htm                        XML    302K 
34: EXCEL       IDEA Workbook of Financial Reports                  XLSX     46K 
 6: EX-101.CAL  XBRL Calculations -- acro-20220630_cal               XML     80K 
 8: EX-101.DEF  XBRL Definitions -- acro-20220630_def                XML    112K 
 5: EX-101.LAB  XBRL Labels -- acro-20220630_lab                     XML    344K 
 7: EX-101.PRE  XBRL Presentations -- acro-20220630_pre              XML    253K 
 4: EX-101.SCH  XBRL Schema -- acro-20220630                         XSD     63K 
36: JSON        XBRL Instance as JSON Data -- MetaLinks              150±   201K 
37: ZIP         XBRL Zipped Folder -- 0001640334-22-001752-xbrl      Zip     85K 


‘R6’   —   Statements of Cash Flows (Unaudited)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.22.2
Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (7,925,440) $ (854,181)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Imputed interest - related parties 420 3,870
Amortization of deferred stock compensation 7,856,200 804,650
Change of ROU and lease liabilities 0 (120)
Changes in operating assets and liabilities:    
Accounts receivable 299,500 0
Inventories (296,000) 490,000
Prepaid expenses (7,128) (7,167)
Accounts payable and accrued expenses (11,197) (12,662)
Net cash provided by (used in) operating activities (83,645) 424,390
CASH FLOWS FROM FINANCING ACTIVITIES    
Advances from related parties 504 14,832
Repayment to related parties 0 (241,851)
Net cash provided by (used in) financing activities 504 (227,019)
Net change in cash (83,141) 197,371
Cash at beginning of period 95,248 18,123
Cash at end of period 12,107 215,494
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for income taxes 0 0
Cash paid for interest $ 0 $ 0

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/12/22
For Period end:6/30/22
6/30/2110-Q,  NT 10-Q
 List all Filings 
Top
Filing Submission 0001640334-22-001752   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 2:56:15.1pm ET